Study of ADAMTS-13 Activity, Von Willebrand Factor and Platelet-Monocyte Aggregation in Coronary Artery Disease

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

TERMINATED

Total Enrollment

11 participants

Study Classification

OBSERVATIONAL

Study Start Date

2009-08-31

Study Completion Date

2010-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this research is to determine the relationship between proteins and enzymes in the blood and how they work with platelets to form blood clots in patients with coronary artery disease. The investigators hypothesize that the relationship between these factors could potentially be useful in identifying patients at higher risk for heart attacks.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Platelet Function in Patients With an Acute Coronary Syndrome

NCT01992484

Acute Coronary Syndrome (ACS)

UNKNOWN

Measurement of Platelet Dense Granule Release in Healthy Volunteers

NCT00942617

Platelet Aggregation

WITHDRAWN NA

Loss of Effect of Aspirin on Platelet Aggregation During Chronic Administration

NCT00748371

Platelet Aggregation

TERMINATED PHASE4

Aspirin in Patients With Myocardial Infarction and Thrombocytopenia

NCT00501345

Thrombocytopenia Myocardial Infarction

TERMINATED PHASE3

Residual Platelet Activity Despite Aspirin Utilization in Coronary Heart Disease

NCT01820429

Coronary Heart Disease Non ST-elevation Acute Coronary Syndromes

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Coronary Artery Disease

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

coronary artery disease

Subjects with coronary artery disease undergoing percutaneous coronary intervention

Blood draws

Intervention Type OTHER

Observational: blood draws only

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Blood draws

Observational: blood draws only

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Admission to hospital with suspected index event of Non-ST-Elevation Myocardial Infarction (NSTEMI), Unstable Angina (UA) or Stable Angina (SA)
* Planned percutaneous coronary intervention during admission

Exclusion Criteria

* Recent history (\< 6 months) of an acute coronary syndrome (other than current admission) or stroke
* Recent history (\< 6 months) of major surgery, trauma or thromboembolic event
* Percutaneous coronary or peripheral intervention or any stent placement performed within the past 6 months
* Current evidence of infection

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No